EMILIN1 and neoplasm: ,20,22,27 Furthermore, using the in vivo CAM assay with FaDu cells, EMILIN-1–overexpressing tumors exhibited significant reductions in tumor growth and Ki-67–positive proliferative cells, along with an increase in the CC3-positive apoptotic cancer cells.